Legalize59765 laws
59765 laws
- § 356j. Discontinuance or interruption in the production of medical devices
- § 356l. Advanced manufacturing technologies designation program
- § 356–1. Accelerated approval of priority countermeasures
- § 356–2. Accelerated approval Council
- § 357. Qualification of drug development tools
- § 358. Authority to designate official names
- § 359. Nonapplicability of subchapter to cosmetics
- § 360. Registration of producers of drugs or devices
- § 360bbb–1. Dispute resolution
- § 360bbb–2. Classification of products
- § 360bbb–3. Authorization for medical products for use in emergencies
- § 360bbb–3a. Emergency use of medical products
- § 360bbb–3b. Products held for emergency use
- § 360bbb–3c. Expedited development and review of medical products for emergency uses
- § 360bbb–4. Countermeasure development, review, and technical assistance
- § 360bbb–4a. Priority review to encourage treatments for agents that present national security threats
- § 360bbb–4b. Medical countermeasure master files
- § 360b–1. Priority zoonotic animal drugs
- § 360c. Classification of devices intended for human use
- § 360cc. Protection for drugs for rare diseases or conditions
- § 360ccc. Conditional approval of new animal drugs for minor use and minor species and certain new animal drugs
- § 360ccc–1. Index of legally marketed unapproved new animal drugs for minor species
- § 360ccc–2. Designated new animal drugs for minor use or minor species
- § 360c–1. Reporting
- § 360ee. Grants and contracts for development of drugs for rare diseases and conditions
- § 360eee. Definitions
- § 360eee–1. Requirements
- § 360eee–2. National standards for prescription drug wholesale distributors
- § 360eee–3. National standards for third-party logistics providers
- § 360eee–4. Uniform national policy
- § 360ee–1. FDA rare neurodegenerative disease grant program
- § 360e–1. Pediatric uses of devices
- § 360e–3. Breakthrough devices
- § 360g. Judicial review
- § 360g–1. Agency documentation and review of significant decisions regarding devices
- § 360g–2. Third party data transparency
- § 360h. Notification and other remedies
- § 360hh. Definitions
- § 360h–1. Program to improve the device recall system
- § 360i. Records and reports on devices
- § 360ii. Program of control
- § 1506. Repealed. [Oct. 10, 1951, ch. 479](/us/act/1951-10-10/ch479), title V, § 503(b)(1), as added [June 20, 1952, ch. 449, § 7(c)](/us/act/1952-06-20/ch449/s7/c), [66 Stat. 144](/us/stat/66/144)
- § 360m. Accredited persons
- § 360mm. Imports
- § 360n. Priority review to encourage treatments for tropical diseases
- § 360nn. Inspection, records, and reports
- § 360n–1. Priority review for qualified infectious disease products
- § 360n–2. Ensuring cybersecurity of devices
- § 360oo. Prohibited acts
- § 364c. Registration and product listing